Dr Reddy's Laboratories Ltd (NYSE:RDY) Stock News, Headlines & Updates
Dr Reddy's Laboratories Ltd Stock News from GuruFocus
- 1
Jun 26, 2024
Dr. Reddy's to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
Business Wire • 11:00am
Jun 03, 2024
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities
Business Wire • 1:00pm
May 28, 2024
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
Business Wire • 9:00am
May 21, 2024
Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Business Wire • 10:00am
May 08, 2024
Q4 2024 Dr Reddy's Laboratories Ltd Earnings Call Transcript
GuruFocus Research • 11:16pm
May 03, 2024
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
Business Wire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news